1. Hood KA. Drug-induced gingival hyperplasia in transplant recipients. Prog Transplant 2002;12:17–21PMID : 11993065.
2. Morgan JD, Swarbrick MJ, Edwards CM, Donnelly PK. Cyclosporin, nifedipine and gingival hyperplasia: a randomized controlled study. Transpl Int 1994;7(Suppl 1):S320–S321PMID : 11271240.
3. Varga E, Mair LH. Medication influencing the development of gingival overgrowth in renal transplant patients. Transplant Proc 1998;30:2120–2121PMID : 9723412.
4. Thomas DW, Newcombe RG, Osborne GR. Risk factors in the development of cyclosporine-induced gingival overgrowth. Transplantation 2000;69:522–526PMID : 10708105.
5. Thomason JM, Seymour RA, Ellis JS, Kelly PJ, Parry G, Dark J, Wilkinson R, Ilde JR. Determinants of gingival overgrowth severity in organ transplant patients: an examination of the role of HLA phenotype. J Clin Periodontol 1996;23:628–634PMID : 8841894.
6. Thomason JM, Seymour RA, Soames JV. Severe mucosal hyperplasia of the edentulous maxilla associated with immunosuppressant therapy: a clinical report. J Prosthet Dent 1994;72:1–3PMID : 8083830.
7. Libertiny G, Watson CJ, Gray DW, Welsh KI, Morris PJ. Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients. Br J Surg 2001;88:1330–1334PMID : 11578286.
8. Caillard S, Lachat V, Moulin B. Post transplant lymphoproliferative disorders in renal allograft recipients: report of 53 cases of a French multicenter study. Transpl Int 2000;13(Suppl 1):S388–S393PMID : 11112039.
9. Stenson KM, Wolf GT, Urba S. Extranodal non-Hodgkin's lymphoma of the head and neck: presentation in the facial bones. Am J Otolaryngol 1996;17:276–280PMID : 8827296.
10. Raut A, Huryn J, Pollack A, Zlotolow I. Unusual gingival presentation of post-transplantation lymphoproliferative disorder: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:436–441PMID : 11027379.
11. Rolland SL, Seymour RA, Wilkins BS, Parry G, Thomason JM. Post-transplant lymphoproliferative disorders presenting as gingival overgrowth in patients immunosuppressed with ciclosporin: a report of two cases. J Clin Periodontol 2004;31:581–585PMID : 15191596.
12. Maxymiw WG, Wood RE, Lee L. Primary, multi-focal, non-Hodgkin's lymphoma of the jaws presenting as periodontal disease in a renal transplant patient. Int J Oral Maxillofac Surg 1991;20:69–70PMID : 2051050.
13. Pan WL, Chan CP, Huang CC, Lai MK, Ju YR, Hsueh C. Primary extramedullary plasmacytoma in cyclosporine-induced gingival overgrowth: a case report. J Periodontol 1995;66:804–807PMID : 7500247.
14. le Meur Y, Potelune N, Jaccard A, Petit B, Bordessoule D, Peyronnet P, Ranger S, Labrousse F, Leroux-Robert C. Lymphoproliferative syndromes after renal transplantation. Nephrologie 1998;19:255–261PMID : 9793938.
15. Seymour RA, Ellis JS, Thomasson JM. Risk factors for drug-induced gingival overgrowth. J Clin Periodontol 2000;27:217–223PMID : 10783833.
16. Penn I. Immunosupression-a contributory factor in lymphoma formation. Clin Transplant 1992;6:210–214.
17. Birkeland SA, Hamilton-Dutoit S. Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se? Transplantation 2003;76:984–988PMID : 14508366.
18. Dharnidharka VR, Ho PL, Stablein DM, Harmon WE, Tejani AH. Mycophenolate, tacrolimus and post-transplant lymphoproliferative disorder. Pediatr Transplant 2002;6:396–399PMID : 12390426.
19. Birkeland SA, Andersen HK, Hamilton-Dutoit SJ. Preventing acute rejection, Epstein-Barr virus infection, and posttransplant lymphoproliferative disorders after kidney transplantation: use of aciclovir and mycophenolate mofetil in a steroid-free immunosuppressive protocol. Transplantation 1999;67:1209–1214PMID : 10342310.
20. Kuo PC, Dafoe DC, Alfrey EJ, Sibley RK, Scandling JD. Posttransplant lymphoproliferative disorders and Epstein-Barr virus prophylaxis. Transplantation 1995;59:135–138PMID : 7839414.
22. Hauke RJ, Greiner TC, Smir BN, Vose JM, Tarantolo SR, Bashir RM, Bierman PJ. Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases. Bone Marrow Transplant 1998;21:1271–1274PMID : 9674863.
23. Liebowitz D. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients. N Engl J Med 1998;338:1413–1421PMID : 9580648.
24. Hoshida Y, Tomita Y, Ohsawa M, Ning X, Aozasa K. Epstein-Barr virus in malignancies in renal transplant recipients in Japan. J Cancer Res Clin Oncol 1997;123:509–513PMID : 9341901.
25. Leblond V, Sutton L, Dorent R, Davi F, Bitker MO, Gabarre J, Charlotte F, Ghoussoub JJ, Fourcade C, Fischer A, et al. Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center. J Clin Oncol 1995;13:961–968PMID : 7707124.
26. Eisenbud L, Sciubba J, Mir R, Sachs SA. Oral presentations in non-Hodgkin's lymphoma: a review of thirty-one cases: part I. data analysis. Oral Surg Oral Med Oral Pathol 1983;56:151–156PMID : 6578477.
27. Howell RE, Handlers JP, Abrams AM, Melrose RJ. Extranodal oral lymphoma: part II. relationships between clinical features and the Lukes-Collins classification of 34 cases. Oral Surg Oral Med Oral Pathol 1987;64:597–602PMID : 3499589.
28. Perkowska A, Durlik M, Suleiman W, Maryniak R, Gaciong Z, Juskowa J, Rostamzadeh Khameneh Z, Szmidt J, Lao M. Posttransplantation lymphoproliferative disorder: case report. Transplant Proc 2000;32:1387–1388PMID : 10995990.